1 November 2024
EnergyPathways plc
("EnergyPathways" or the "Company")
Exercise of warrants
EnergyPathways plc (AIM: EPP), an integrated energy transition company, announces that it has received notices to exercise a total of 2,502,500 warrants over new ordinary shares in the Company ("Warrant Shares"). 250,000 warrants were exercised at 5p per ordinary share and 2,252,500 at an exercise price of 4p per ordinary share, raising a total of £102,600 for the Company.
Admission and Total Voting Rights
Application will be made for the Warrant Shares and the Fee Shares to be admitted to trading on AIM, which is expected to occur on or around 6 November 2024 ("Admission"). The Warrant Shares will rank pari passu in all respects with the Company's existing ordinary shares currently traded on AIM.
Following Admission, the Company's issued share capital will comprise 163,707,845 ordinary shares of 1 pence each. This number will represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
Enquiries:
| EnergyPathways
| Tel: +44 (0)20 7466 5000, c/o Buchanan (Financial PR) Email : info@energypathways.uk |
| Cairn Financial Advisers LLP (Nominated Adviser) | Tel: +44 (0)20 7213 0880 |
| SP Angel Corporate Finance LLP (Joint Broker) | Tel: +44 (0)20 3470 0470 |
| Global Investment Strategy UK Limited (Joint Broker) | Tel: +44 (0)20 7048 9000 |
| Buchanan (Financial PR) | Tel: +44 (0)20 7466 5000 |
For further information on EnergyPathways visit www.energypathways.uk and @energy_pathways on X (formerly Twitter).
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
